Tiffany Pon, PharmD
Associate Professor
Clinical Pharmacy
School of Pharmacy

Dr. Tiffany Pon is an Associate Professor of Clinical Pharmacy in the Department of Clinical Pharmacy at the University of California, San Francisco. Her clinical practice site is at the University of California, Davis Medical Center (UCDMC) where she provides clinical services in internal medicine. She is also the Program Director for the Greater Sacramento Area Experiential Education site.

Show full bio (35 words) Hide full bio

Research interests primarily involve anticoagulation (dosing and application in special populations) and experiential education. She is also passionate about leadership within the profession and is an active member of the American College of Clinical Pharmacy.

Awards

Show all (4) Hide

• Long Award for Excellence in Teaching, University of California, San Francisco, 2017
• Apples of Preceptor Award, University of California, San Francisco, 2016-2021
• Long Award for Excellence in Teaching, University of California, San Francisco, 2014
• Pharmacy Resident of the Year, UC Davis Medical Center, 2012

Publications (11)

Top publication keywords:
BenzimidazolesAntithrombinsCesarean SectionPulmonary Disease, Chronic ObstructivePreceptorshipAnticoagulantsSocieties, PharmaceuticalPharmacy ResidenciesAcademic Medical Centersbeta-AlaninePre-Exposure ProphylaxisEducation, Pharmacy, GraduateVenous ThromboembolismKidney Failure, ChronicEnoxaparin

• Evaluation of standard versus reduced dose apixaban for the treatment of venous thromboembolism in patients with severe renal disease (ESRD-VTE).
  Thrombosis research 2022 Knueppel P, Bang SH, Troyer C, Barriga A, Shin J, Cadiz CL, Abdo C, McCart T, Huynh B, Stevens C, Zhou C, Yang NT, Wilson M, Pon T
• Cost Comparison of Oral Linezolid and Intravenous Vancomycin for Empiric Treatment of Suspected MRSA Pneumonia
  Journal of Contemporary Pharmacy Practice 2022 Jefferson Cua, PharmD, BCIDP; Kei Takamura, PharmD, BCPS, BCPP; Kathie H. Le, Pharm.D, BCPS; Matthew Serna, PharmD, BCPS; Denise Roach, PharmD, BCGP; Elle Zhu, PharmD; Tiffany Pon, PharmD, BCPS
• Pharmacy Resident Perspectives on the Layered Learning Practice Model.
  Hospital pharmacy 2022 Dang NV, Pon TK, Hellier YM
• Optimizing quality of care in patients admitted with chronic obstructive pulmonary disease exacerbation.
  Chronic respiratory disease 2022 Tsao M, Laikijrung C, Tran A, Pon T, Roach D, Liu B, Le K
• Direct oral anticoagulants or low-molecular-weight heparins for venous thromboembolism in patients with brain tumors.
  Thrombosis research 2021 Lee A, Oley F, Lo M, Fong R, McGann M, Saunders I, Block S, Mahajan A, Pon TK

Show all (6 more) Hide

• Utilization of venous thromboembolism prophylaxis in American hospitalized pregnant women undergoing cesarean section.
  International journal of clinical pharmacy 2019 Pon TK, Wessel N, Cagonot V, Delmonte R, Roach D, Finta L
• Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia.
  Journal of thrombosis and thrombolysis 2018 Pon TK, Mahajan A, Rosenberg A, Amin A, Shah D, Jenkins I, Gupta V, Hofmann H, Bejjani A, White R
• Preceptor development: Responses to frequently asked questions from preceptors in academic hospitals.
  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2016 Phillips HJ, Dangler A, Klem PM, Chu F, Pon T, Liewer S, Thompson Bastin ML, Halfpap JJ, Fish J, Stun L, Varughese CA
• Considerations for Systemic Anticoagulation in ESRD.
  Seminars in dialysis 2015 Dager WE, Tsu LV, Pon TK
• A retrospective descriptive analysis of patient adherence to dabigatran at a large academic medical center.
  Journal of managed care & specialty pharmacy 2014 Cutler TW, Chuang A, Huynh TD, Witt RG, Branch J, Pon T, White R
• Subcutaneous enoxaparin for therapeutic anticoagulation in hemodialysis patients.
  Thrombosis research 2014 Pon TK, Dager WE, Roberts AJ, White RH